Literature DB >> 26856747

Is the Hype of Medical Marijuana All Smoke and Mirrors?

Jenna Koliani-Pace1, Corey A Siegel1.   

Abstract

Being classified as a Schedule I drug by the Federal government has not prevented states from passing their own medical marijuana laws. While there is no denying that marijuana's euphoria makes people feel better, there is a lack of scientific data to support the efficacy of marijuana for gastrointestinal diseases. Marijuana, when used as a medical treatment, should be held to the same standards as any other drug coming to market including investigating the adverse event profile and ensuring a rigorous quality control program. Although we are not writing a prescription in the classic definition, we are signing state paperwork supporting the use as a treatment for a medical illness. Therefore, we have the obligation to our patients to ensure that we are recommending a safe and effective drug. More research needs to be conducted until we can reach that conclusion.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26856747     DOI: 10.1038/ajg.2016.4

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  4 in total

Review 1.  Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.

Authors:  Penny F Whiting; Robert F Wolff; Sohan Deshpande; Marcello Di Nisio; Steven Duffy; Adrian V Hernandez; J Christiaan Keurentjes; Shona Lang; Kate Misso; Steve Ryder; Simone Schmidlkofer; Marie Westwood; Jos Kleijnen
Journal:  JAMA       Date:  2015 Jun 23-30       Impact factor: 56.272

Review 2.  Adverse health effects of marijuana use.

Authors:  Nora D Volkow; Ruben D Baler; Wilson M Compton; Susan R B Weiss
Journal:  N Engl J Med       Date:  2014-06-05       Impact factor: 91.245

Review 3.  Medical marijuana for digestive disorders: high time to prescribe?

Authors:  Mark E Gerich; Robert W Isfort; Bryan Brimhall; Corey A Siegel
Journal:  Am J Gastroenterol       Date:  2014-09-09       Impact factor: 10.864

4.  Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study.

Authors:  Timna Naftali; Lihi Bar-Lev Schleider; Iris Dotan; Ephraim Philip Lansky; Fabiana Sklerovsky Benjaminov; Fred Meir Konikoff
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-04       Impact factor: 11.382

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.